Sophie M. Tops
Leuven, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Conformation-specific monoclonal antibodies reveal early Tau structural intermediates in Alzheimer's disease.
Journal: The Journal of biological chemistry
Published: December 01, 2025
Real-world Endoscopic and Histological Outcomes Are Correlated with Ustekinumab Exposure in Patients with Ulcerative Colitis.
Journal: Journal of Crohn's & colitis
Published: March 15, 2022
Infliximab Concentrations during Induction Are Predictive for Endoscopic Remission in Pediatric Patients with Inflammatory Bowel Disease under Combination Therapy.
Journal: The Journal of pediatrics
Published: April 23, 2021
Evaluating an easy sampling method using dried blood spots to determine vedolizumab concentrations.
Journal: Journal of pharmaceutical and biomedical analysis
Published: November 04, 2019
Evaluating Efficacy, Safety, and Pharmacokinetics After Switching From Infliximab Originator to Biosimilar CT-P13: Experience From a Large Tertiary Referral Center.
Journal: Inflammatory bowel diseases
Published: October 25, 2019
Influence of Drug Exposure on Vedolizumab-Induced Endoscopic Remission in Anti-Tumour Necrosis Factor [TNF] Naïve and Anti-TNF Exposed IBD Patients.
Journal: Journal of Crohn's & colitis
Published: September 11, 2019
Anti-infliximab antibodies: How to compare old and new data?
Journal: Journal of pharmaceutical and biomedical analysis
Published: July 10, 2019
Impact of first-line infliximab on the pharmacokinetics of second-line vedolizumab in inflammatory bowel diseases.
Journal: United European gastroenterology journal
Published: January 29, 2019
Early vedolizumab trough levels at induction in inflammatory bowel disease patients with treatment failure during maintenance.
Journal: European journal of gastroenterology & hepatology
Published: January 24, 2019
Evaluating Efficacy, Safety, and Pharmacokinetics After Switching From Infliximab Originator to Biosimilar CT-P13: Experience From a Large Tertiary Referral Center.
Journal: Inflammatory bowel diseases
Published: January 02, 2019
Early vedolizumab trough levels predict combined endoscopic and clinical remission in inflammatory bowel disease.
Journal: United European gastroenterology journal
Published: December 11, 2018
Incidence and microbiology of post-operative infections after radical cystectomy and ureteral stent removal; a retrospective cohort study.
Journal: BMC infectious diseases
Published: November 19, 2018
Last Updated: 09/26/2026